Gleevec – From Bench To Clinic

Gleevec – From Bench To Clinic. Nick Lydon, Ph.D. discovered and co-developed the leukemia drug Gleevec. In this discussion, which is part of the Frontiers In Cancer Research series of talks at UC Santa Barbara, Lydon talks about the scientific process of discovering this drug and how it was tested to determine its effectiveness in battling leukemia.